The physiological signaling mechanisms that link normal variations in body energy status to the activity of arousal-and metabolismregulating brain centers are not well understood. The melanin-concentrating hormone (MCH) and orexin/hypocretin types of neurons of the lateral hypothalamus (LH) exert opposing effects on arousal and metabolism. We examined whether shifts in brain extracellular glucose that correspond to physiological changes in blood glucose can alter the electrical output of neurochemically and biophysically defined LH cells in mouse brain slices. Here, we show that physiologically relevant concentrations of glucose dose-dependently enhance the electrical excitability of MCH neurons by inducing depolarization and increasing membrane resistance. We also demonstrate that the same physiological shifts in glucose have the opposite effects on the electrical activity of orexin neurons. We propose that these direct actions of glucose on the arousal-and metabolism-regulating LH neurons play a key role in the translation of normal variations in body energy resources into appropriate changes in arousal and metabolism.
Introduction
In mammals, arousal is reduced after feeding and increased during fasting (Danguir and Nicolaidis, 1979; Dewasmes et al., 1989; Harnish et al., 1998; Yamanaka et al., 2003b ), yet the physiological signaling mechanisms that couple body energy status to the activity of wakefulness-and metabolism-regulating brain centers are not well understood. The activity of neurons in the lateral hypothalamus (LH) is vital for normal sleep-wake behavior and body energy metabolism (Shimada et al., 1998; Saper et al., 2001; Willie et al., 2001; Sutcliffe and de Lecea, 2002; Taheri et al., 2002; Pissios and Maratos-Flier, 2003; Yamanaka et al., 2003b) , and it has been recognized since the 1960s that some of these cells specifically respond to elevations in extracellular glucose with increased or decreased electrical activity (Oomura et al., 1969) . However, the physiological significance of this potential arousalmodulating signaling pathway remained unsettled (Routh, 2002) because of the lack of knowledge about the functional identities of LH neurons whose electrical output is sensitive to physiologically relevant changes in ambient levels of glucose.
Two types of LH neurons, those expressing the neuropeptides melanin-concentrating hormone (MCH) and orexins (hypocretins), recently emerged as critical regulators of sleep-wake behavior and energy balance (Shimada et al., 1998; Willie et al., 2001; Sutcliffe and de Lecea, 2002; Pissios and Maratos-Flier, 2003; Verret et al., 2003; Yamanaka et al., 2003b; Burdakov, 2004) , but it has not been established whether the electrical activity of these vital cells is sensitive to physiological changes in glucose. Although the firing of isolated LH orexin neurons is inhibited by glucose in the 5-30 mM concentration range (Yamanaka et al., 2003b) , it is unknown whether this occurs in situ at physiologically relevant concentrations of brain glucose, which are Ͻ5 mM (Silver and Erecinska, 1994; de Vries et al., 2003) . The impact of changes in extracellular glucose on the electrical output of MCH neurons has not been explored.
In this study, we analyzed the electrical responses of LH MCH and orexin neurons to physiological shifts in extracellular glucose in mouse brain slices, using patch-clamp recordings and postrecording immunocytochemistry.
Materials and Methods
Electrophysiology. Procedures involving animals were performed in accordance with the United Kingdom Animals (Scientific Procedures) Act of 1986. Brain slices containing the LH (bregma coordinates corresponding to between Ϫ1.2 and Ϫ2 mm in adult mice) were prepared from male C57BL/6 mice (postnatal days 13-16), and whole-cell patch-clamp recordings and data analysis were performed as described previously (Burdakov et al., 2003) . Experiments were performed at room temperature (22-24°C). Extracellular solution was artificial CSF gassed with 95% O 2 and 5% CO 2 and contained the following (in mM): 118 NaCl, 25 NaHCO 3 , 3 KCl, 1.2 NaH 2 PO 4 , 2 CaCl 2 , 2 MgCl 2 , and 0.2-5 glucose. When the extracellular glucose concentration was altered, osmolarity was balanced with sucrose. Patch pipettes had tip resistances of 3-5 M⍀ when filled with internal solution containing the following (in mM): 120 K-gluconate, 10 KCl, 0.1 EGTA, 10 HEPES, 4 K 2 -ATP, 1 Na 2 ATP, and 2 MgCl 2 , pH 7.3 with KOH. All of the chemicals were from Sigma (Poole, Dorset, UK). Series resistance was Ͻ10 M⍀ throughout the recording and was not compensated. Data are given as mean Ϯ SEM. Concentration-response data were fitted with a modified Hill equation, (or IC 50 ) is the concentration of glucose at which the V m change is halfmaximal. Parameter values used to obtain specific fits of the equation to the data are given in the relevant figure legends (see Figs. 1 E, 2E) .
Immunocytochemistry and confocal microscopy. For postrecording neurochemical identification of LH neurons, 0.2% Neurobiotin tracer (Vector Laboratories, Peterborough, UK) was added to the pipette solution. Neurons were maintained in the whole-cell configuration for 5-10 min to allow thorough infusion of Neurobiotin, after which the patch pipette was gently withdrawn via the outside-out configuration. Slices were then fixed in 4% paraformaldehyde (Sigma) in PBS, pH 7.4, for 1 h at room temperature, incubated with primary antibodies overnight, and then incubated with fluorescent secondary antibodies for 3 h, following a previously published protocol (Wolfart et al., 2001 ). The primary antibodies and labels were Neurobiotin, rabbit anti-orexin-A (1:250) (Phoenix Pharmaceuticals, Karlsruhe, Germany), and chicken anti-MCH (1:250) (BMA Biomedicals, Augst, Switzerland). The corresponding secondary antibodies and labels were streptavidin-cyanine 2 (Cy2) (1:500) (Amersham Biosciences, Bucks, UK), goat anti-rabbit-Cy5 (1:500) (Amersham Biosciences), and goat anti-chicken-Alexa Fluor 555 (1:500) (Molecular Probes, Eugene, OR). The specificity of the antibodies we used was established in previous studies (Chen et al., 1999; Pereira-da-Silva et al., 2003) . Slices were analyzed using a Leica Microsystems (Mannheim, Germany) TCS SP2 confocal laser-scanning microscope. Cy2 (shown in green; see Figs. 1B, 2B) was excited with an argon laser at 488 nm, and fluorescence emission was collected at 505-530 nm. Alexa Fluor 555 (red) and Cy5 (yellow) were excited with HeNe lasers at 543 and 633 nm, respectively, and emission was detected at 560 -615 and 650 -700 nm. To achieve optimal separation of fluorescent signals, the sequential "between lines" scanning mode of the microscope was used.
Results

Identification of MCH and orexin neurons in brain slices
We identified MCH and orexin cells by their distinctive electrophysiological properties and postrecording immunocytochemistry. MCH neurons are electrically silent, do not display H-current-mediated depolarization, and exhibit pronounced spike-rate adaptation (Eggermann et al., 2003; van den Pol et al., 2004) . Using postrecording triple-label immunocytochemistry to correlate electrophysiological signature with expression of MCH and orexin peptides (see Materials and Methods), we confirmed that all LH neurons that displayed this combination of properties ( Fig. 1 A) contained MCH and not orexin (n ϭ 30 of 30) (Fig. 1 B) .
In contrast to MCH neurons, orexin neurons exhibit tonic spontaneous firing, H-currents, low-threshold spike on recovery from hyperpolarization, and little spike-rate adaptation (Li et al., 2002; Eggermann et al., 2003; Yamanaka et al., 2003a; Burdakov et al., 2004) . We confirmed by postrecording immunocytochemistry that all LH neurons displaying the latter set of properties (Fig. 2 A) contained orexin and not MCH peptides (n ϭ 35 of 35) ( Fig. 2 B) . Our qualitative electrophysiological criteria (Figs. 1 A,  2 A) therefore provide a highly reliable way of identifying MCH and orexin neurons in our in situ preparation.
Physiological concentrations of glucose excite MCH neurons
In vivo, extracellular glucose concentration in the brain varies between ϳ0.2 mM during systemic hypoglycemia and ϳ5 mM during hyperglycemia [measurements from rat brain (Silver and Erecinska, 1994) ]. Changing extracellular glucose from 0.2 to 5 mM reversibly depolarized MCH neurons (n ϭ 15 of 18) (Fig.  1C) . This depolarization was accompanied by the appearance of spiking responses to depolarizing current pulses that failed to induce action potentials in 0.2 mM glucose (n ϭ 15 of 15) (Fig.  1 D) and by induction of spontaneous firing in 4 of 15 MCH neurons (Fig. 1C) . Glucose-induced depolarization of MCH neurons was dose dependent with half-maximal effect at 0.8 mM (Fig.  1 E) and was associated with an increase in membrane resistance (calculated from membrane potential changes in response to a series of 10 -40 pA hyperpolarizing current pulses, such as those shown in Fig. 1 F) . Membrane resistance increased by 74 Ϯ 18% in 5 mM glucose compared with control values in 0.2 mM glucose measured in the same cell (n ϭ 8). The largest resistance increase observed was from 400 to 1100 M⍀, and the smallest was from 650 to 800 M⍀ in 0.2 and 5 mM glucose, respectively. Reversible glucose-induced depolarization and resistance increase persisted when neurons were synaptically isolated with tetrodotoxin (n ϭ 4) (Fig. 1 F) , consistent with a direct postsynaptic action of glucose on MCH neurons.
Physiological concentrations of glucose inhibit orexin neurons
The same physiological changes in glucose had the opposite effects on LH orexin neurons. Elevating glucose from 0.2 to 5 mM induced hyperpolarization and suppressed both spontaneous (Fig. 2C) and evoked (Fig. 2 D) firing in 20 of 21 orexin neurons. Glucose-induced hyperpolarization of orexin neurons was concentration dependent with half-maximal response at 3.5 mM (Fig.  2 E) and was accompanied by a pronounced decrease in membrane resistance (Fig. 2 F) . Membrane resistance fell by 66 Ϯ 3% in 5 mM glucose compared with control values in 0.2 mM glucose measured in the same cell (n ϭ 7). The largest resistance decrease was from 1000 to 250 M⍀, and the smallest was from 1160 to 530 M⍀ in 0.2 and 5 mM glucose, respectively. The hyperpolarization and resistance decrease persisted in tetrodotoxin (n ϭ 5) (Fig.  2F) , indicating a direct postsynaptic action of glucose on orexin neurons.
Discussion
Effects of glucose on MCH and orexin neurons
In this study, we show for the first time that physiologically relevant concentrations of glucose directly enhance the electrical excitability of MCH neurons by causing depolarization and increasing membrane resistance but inhibit the firing of orexin neurons by triggering hyperpolarization and decreasing membrane resistance. Crucially, our concentration-response analysis (Figs. 1 E,   Figure 2 . Electrical responses of LH orexin neurons to physiological changes in glucose. A, Defining electrical signature of orexin neurons: tonic spontaneous firing (i), H-currentmediated sag (ii), low-threshold spike (iii), and little spike-rate adaptation (iv). Current-clamp protocols used to elicit these responses are shown schematically below corresponding traces. B, Immunofluorescence imaging of the cell shown in A, identified by Neurobiotin staining (green); the cell contains orexin-A (yellow) but not MCH (red). Scale bar, 20 m. C, Glucose induced reversible hyperpolarization and inhibited spiking in an orexin neuron. D, Glucose suppressed the spiking response to depolarizing current injection (40 pA for 3 s; protocol shown schemat-4 ically below the traces); this effect was reversible after glucose washout. E, Dose-response relationship of glucose-induced hyperpolarization of orexin cells (IC 50 ϭ 3.5 mM; h ϭ 1.8; V max ϭ Ϫ78.8 mV; V 0 ϭ Ϫ42.9 mV; the general equation of the fit is given in Materials and Methods). Numbers of cells are indicated above corresponding points. F, In the presence of tetrodotoxin (TTX) (300 nM), glucose induced hyperpolarization and decreased membrane resistance (resistance was monitored as described in Fig. 1F ) .
2 E) showed that these effects were steepest within the physiological window of brain glucose levels (Silver and Erecinska, 1994) and would be expected to occur in response to variations in hypothalamic glucose associated with changes in food intake (de Vries et al., 2003) .
The effects of glucose on membrane resistance imply that glucose suppresses an inhibitory ionic conductance in MCH neurons but activates an inhibitory conductance in orexin neurons. In other neurons that electrically respond to changes in glucose, glucose-induced excitation is thought to be attributable to the closure of ATP-sensitive K ϩ channels, whereas glucose-induced inhibition has been proposed to involve activation of a Cl Ϫ conductance (Levin et al., 2004; Song and Routh, 2005) . The biophysical identities of glucose-modulated conductances in MCH and orexin neurons remain to be determined. Another important subject for future investigation is the developmental profile of the glucose responses; it would be of particular interest to compare glucose sensitivity of LH neurons from young mice used here with that of LH cells from older animals.
Our recordings show that stimulating orexin neurons with 10 mM glucose for several minutes caused them to assume hyperpolarized membrane potentials (approximately Ϫ74 mV on average) and completely abolished their firing (Fig. 2E) . In contrast, other recent reports indicate that after LH brain slices have been maintained in 10 mM glucose for a long time (throughout postslicing recovery and subsequent experiments), orexin neurons exhibit depolarized membrane potentials and spontaneous firing (Li et al., 2002; Eggermann et al., 2003; Yamanaka et al., 2003a; Burdakov et al., 2004) . One potential explanation for this apparent difference between short-and long-term responses to changes in glucose levels is that orexin neurons could possess adaptive homeostatic mechanisms (Marder and Prinz, 2002) , which, when faced with sustained changes in glucose, may gradually return the electrical properties of orexin cells to an intrinsic set point, such as the depolarized and spontaneously firing state (Eggermann et al., 2003) .
Implications for wakefulness and energy balance
Both MCH and orexin neurons of the LH innervate multiple brain areas that control appetite, metabolism, and sleep-wake behavior (Bittencourt et al., 1992; Peyron et al., 1998) . MCH promotes sleep (Verret et al., 2003) and suppresses metabolism (Segal-Lieberman et al., 2003) , and its knock-out produces a lean mouse (Shimada et al., 1998) . This implies that the excitatory actions of glucose on MCH neurons (Fig. 1 ) may promote rest and energy conservation when body energy resources are high (e.g., after feeding). Conversely, decreased excitability of MCH neurons caused by a fall in glucose would be expected to suppress sleepiness and promote activity, which is advantageous for effective food seeking.
In contrast to MCH, orexins promote wakefulness and stimulate metabolism, whereas destruction of orexin neurons causes narcolepsy (Willie et al., 2001; Sutcliffe and de Lecea, 2002; Taheri et al., 2002) . It was proposed recently that disinhibition of orexin neurons caused by falling levels of glucose may mediate the increased wakefulness and activity that accompany fasting (Yamanaka et al., 2003b ), yet the physiological significance of this pathway remained controversial because inhibition of the electrical output of orexin neurons by physiological concentrations of glucose in situ has not been demonstrated. Our new results (Fig.  2) now provide the crucial physiological evidence that orexin neurons in situ indeed dramatically alter their spontaneous and evoked electrical output in response to changes in ambient glucose that correspond to different metabolic states in vivo (Silver and Erecinska, 1994; de Vries et al., 2003) .
In summary, our data offer an integrated biophysical and neurochemical explanation for how LH glucose-sensing neurons translate subtle physiological variations in glucose levels into appropriate adaptive changes in arousal and energy metabolism. This may also be relevant to understanding the pathogenesis of narcolepsy and body-weight disorders.
